MedPath
NMPA Approval

Ramucirumab Injection

国药准字SJ20220012

March 16, 2022

Drug Information

雷莫西尤单抗注射液

希冉择

注射剂

100mg/10mL

生物制品

March 16, 2022

March 15, 2027

Company Information

Applicant Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

Manufacturing Company

Lilly Corporate Center, Indianapolis, IN 46285 United States of America

© Copyright 2025. All Rights Reserved by MedPath
雷莫西尤单抗注射液 - NMPA 批准文号 | MedPath